Rethinking ethical oversight in the era of the learning health system.


Journal

Healthcare (Amsterdam, Netherlands)
ISSN: 2213-0772
Titre abrégé: Healthc (Amst)
Pays: Netherlands
ID NLM: 101622189

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 13 04 2020
revised: 21 07 2020
accepted: 06 08 2020
pubmed: 30 9 2020
medline: 30 6 2021
entrez: 29 9 2020
Statut: ppublish

Résumé

Opportunities to advance science increasingly arise through investigations embedded within routine clinical practice in the form of learning health systems. Such activities challenge conventional approaches to research regulation that have not caught up with those opportunities, often imposing burdens generalized from riskier research. We analyze the rules and conventions in the US, demonstrating how even those rules are compatible with a much more flexible approach to participant risk, institutional oversight, participant consent, and disclosure for low-risk learning activities in all jurisdictions.

Identifiants

pubmed: 32992106
pii: S2213-0764(20)30061-0
doi: 10.1016/j.hjdsi.2020.100462
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100462

Informations de copyright

Published by Elsevier Inc.

Auteurs

David A Asch (DA)

University of Pennsylvania, Philadelphia, PA, USA; Cpl Michael J Crescenz VA Medical Center, Philadelphia, PA, USA. Electronic address: asch@wharton.upenn.edu.

Steven Joffe (S)

University of Pennsylvania, Philadelphia, PA, USA.

Barbara E Bierer (BE)

Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Sarah M Greene (SM)

SG Strategies, Seattle, WA, USA.

Tracy A Lieu (TA)

Kaiser Permanente Northern California, The Permanente Medical Group, Oakland, CA, USA.

Jodyn E Platt (JE)

University of Michigan Medical School, Ann Arbor, MI, USA.

Danielle Whicher (D)

National Academy of Medicine, Washington, DC, USA.

Mahnoor Ahmed (M)

National Academy of Medicine, Washington, DC, USA.

Richard Platt (R)

Harvard Medical School, Boston, MA, USA; Harvard Pilgrim Health Care Institute, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH